Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Intern Med. 2018 Feb 19;283(3):218–237. doi: 10.1111/joim.12732

Table 1.

Tau ligands distinguish between tau pathologies in different diseases.

Ligand Tau
AD PSP FTD CBD P301S (mouse)
Congo Red + + + + +
FDDNP + +
T807* (AV-1451) +
THK-523* +
PBB3 + + + + +

AD = Alzheimer’s disease; PSP = progressive supranuclear palsy; FTD = frontotemporal dementia; CBD = corticobasal degeneration; P301S = tau P301S mutant expressed in a tg-mouse model of FTD/CBD.

*

T807 and THK-523 bind to distinct sites on tau.